Bacil Pharma to Incorporate Wholly-Owned R&D Subsidiary

Bacil Pharma Limited announced its intention to establish a new wholly-owned subsidiary, "Bacil Research & Development Private Limited". This move is subject to regulatory approvals. The subsidiary's primary objective will be to conduct research and development activities, along with other allied business functions permitted by law. This strategic initiative aims to bolster the company's innovation pipeline and future growth prospects.